Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus

Journal of Lipid Research

Volumn 50, Issue 9, 2009, Pages 1901-1909

  Reyes Soffer, Gissette ^a   Holleran, Steve ^a   Karmally, Wahida ^a   Ngai, Colleen I ^a   Chen, Niem Tzu ^a   Torres, Margarita ^a   Ramakrishnan, Rajasekhar ^a   Blaner, William S ^a   Berglund, Lars ^a   Ginsberg, Henry N ^a   Tuck, Catherine ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Apolipoprotein B48; Remnant lipoproteins; Triglycerides

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEIN B-48; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SEX FACTORS; TRIGLYCERIDES;

EID: 70350786366     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M900092-JLR200     Document Type: Article

References (39)

1. Stamler, J., O. Vaccaro, J. D. Neaton, and D. Wentworth. 1993. Diabetes, other risk factors, and 12 yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16: 434-444.
2. Krauss, R. M., and P. W. Siri. 2004. Metabolic abnormalities: triglyceride and low-density lipoprotein. Endocrinol. Metab. Clin. North Am. 3: 405-415.
3. Chahil, T. J., and G. N. Ginsberg. 2006. Diabetic dyslipidemia. Endocrinol. Metab. Clin. North Am. 35: 491-510.
4. Hulley, S. B., R. H. Rosenman, R. D. Bawol, and R. J. Brand. 1980. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N. Engl. J. Med. 302: 1383-1389.
5. Ginsberg, H. N. 2002. New perspectives on atherogenesis/role of abnormal triglyceride rich lipoprotein metabolism. Circulation. 106: 2137-2142.
6. Hokanson, J. E., and M. A. Austin. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3: 213-219.
7. Sarwar, N., J. Danesh, G. Eiriksdottir, G. Sigurdsson, N. Wareham, S. Bingham, S. M. Boekholdt, K. T. Khaw, and V. Gudnason. 2007. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 subjects in 29 Western prospective studies. Circulation. 115: 450-458.
8. Bansal, S., J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 298: 309-316.
9. Nordestgaard, B. G., M. Benn, P. Schnohr, and A. Tybjaerg-Hansen. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 298: 299-308.
10. Simons, L. A., T. Dwyer, J. Simons, L. Bernstein, P. Mock, N. S. Poonia, S. Balasubramaniam, D. Baron, J. Branson, J. Morgan, et al. 1987. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis. 65: 181-189.
11. Simpson, H. S., C. M. Williamson, T. Olivecrona, S. Pringle, J. Maclean, A. R. Lorimer, F. Bonnefous, Y. Bogaievsky, C. J. Packard, and J. Sheperd. 1990. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 85: 193-202.
12. Groot, P. H. E., W. A. H. J. van Stiphout, X. H. Krauss, H. Jansen, A. van Tol, E. van Ramshorst, S. Chin-on, A. Hofman, S. R. Cresswell, and L. Havekes. 1991. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler. Thromb. 11: 653-662.
13. Ginsberg, H. N., J. Jones, W. S. Blaner, A. Thomas, W. Karmally, L. Fields, D. Blood, and M. D. Begg. 1995. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15: 1829-1838.
14. Sharret, A. R., L. E. Chambless, G. Heiss, C. C. Paton, and W. Patsch. 1995. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15 2122-2129.
15. Syvanne, M., H. Hilden, and M-R. Taskinen. 1994. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J. Lipid Res. 35: 15-26.
16. Mero, N., R. Malmstrom, G. Steiner, M-R. Taskinen, and M. Syvann. 2000. Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis. 150: 167-177.
17. Carstensen, M., C. Thomsen, O. Gotzsche, J. J. Holst, J. Schrezenmeir, and K. Hermansen. 2004. Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction. Rev. Diabet. Stud. 1: 175-184.
18. Friedewald, W. T., R. I. Levy, and D. S. Drederickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative centrifuge. Clin. Chem. 18: 499-502.
19. Nagashima K., Lopez C., Donovan D., Ngai C., Fontanez N., Bensadoun A., Fruchart-Najib J., Holleran S., Cohn J.S., Ramakrishnan R., et al. Effects of the PPAR agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. JCI 1323-1332, 2005
20. Otvos, J. 1999. Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy. Clin. Cardiol. 22 (Suppl. 6): II21-27.
21. Kinoshita, M., M. Kojima, T. Matsushima, and T. Teramoto. 2005. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin. Chim. Acta. 351: 115-120.
22. Nakajima, K., T. Saito, A. Tamura, M. Suzuki, T. Nakano, M. Adachi, A. Tanaka, N. Tada, H. Nakamura, and E. Campos. 1993. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apo A-I immunoaffinity mixed gels. Clin. Chim. Acta. 223: 53-71.
23. Bieri, J. G., T. J. Tolliver, and G. L. Catignani. 1979. Simultaneous determination of a-tocopherol and retinol in plasma or red cells by high-pressure liquid chromatography. Am. J. Clin. Nutr. 32: 2143-2149.
24. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80: 1571-1577.
25. Nordestgaard, B. G., R. Wootton, and B. Lewis. 1995. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler. Thromb. Vasc. Biol. 15: 534-542.
26. Nordestgaard, B. G., A. Tybjaerg-Hansen, and B. Lewis. 1992. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler. Thromb. 12: 6-18.
27. Ginsberg, H. N. 2001. Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy. Am. J. Cardiol. 87: 1174-1180.
28. Meyer, E., H. T. Westerveld, F. C. Ruyter-Meijstek, M. M. J. Van Greevebroek, R. Rienks, H. J. M. Rijn, D. W. Erkelens, and T. W. A. Bruin. 1996. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis. 124: 221-235.
29. Mero, N., M. Syvanne, and M. R. Taskinen. 1998. Postprandial lipid metabolism in diabetes. Atherosclerosis. 141: S53-55.
30. Syvanne, M., P. J. Talmud, S. E. Humphries, R. M. Fisher, M. Rosseneu, H. Hilden, and M. R. Taskinen. 1997. Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J. Lipid Res. 38: 1463-1472.
31. Cohn, J. S., J. R. McNamara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human participant subjects fed a fatrich meal. J. Lipid Res. 29: 925-936.
32. Knopp, R. H., M. D'Emden, J. G. Smilde, and S. J. Pocock. 2006. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in participant subjects with type 2 diabetes. Diabetes Care. 29: 1478-1485.
33. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, and R. M. Krauss. 1988. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260: 1917-1921.
34. Lamarche, B., A. Tchernof, S. Moorjani, B. Cantin, G. R. Dagenais, P. J. Lupien, and J. P. Després. 1997. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation. 95: 69-75.
35. Mora, S., M. Szkio, J. D. Otvos, P. Greenland, B. M. Psaty, D. C. Goff, Jr., D.H. O'Leary, M.F. Saad, M.Y. Tsai, and A. Sharrett. 2007. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 192: 211-217.
36. Stampfer, M. J., R. M. Krauss, J. Ma, P. J. Blanche, L. G. Holl, F. M. Sacks, and C. H. Hennekens. 1996. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 276: 882-888.
37. Sacks, F. M., and H. Campos. 2003. Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J. Clin. Endocrinol. Metab. 88: 4525-4532.
38. El Harchaoui, K., W. A. van der Steeg, E. S. Stroes, J. A. Kuivenhoven, J. D. Otvos, N. J. Wareham, B. A. Hutten, J. J. Kastelein, K. T. Khaw, and S. M. Boekholdt. 2007. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J. Am. Coll. Cardiol. 49: 547-553.
39. Suter, P. M., G. Marmier, C. Veya-Linder, E. Hanseler, J. Lentz, W. Vetter, and J. D. Otvos. 2005. Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size. Atherosclerosis. 180: 127-135.